Journal:JBSD:36
From Proteopedia
(Difference between revisions)

(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
<StructureSection load='' size='450' side='right' scene='Journal:JBSD:36/Cv/2' caption=''> | <StructureSection load='' size='450' side='right' scene='Journal:JBSD:36/Cv/2' caption=''> | ||
=== Structural Insights into the South African HIV-1 Subtype C Protease: Impact of hinge region dynamics and flap flexibility in drug resistance === | === Structural Insights into the South African HIV-1 Subtype C Protease: Impact of hinge region dynamics and flap flexibility in drug resistance === | ||
- | <big>Previn Naicker, Ikechukwu Achilonu, Sylvia Fanucchi, Manuel Fernandes, Mahmoud A.A. Ibrahim, Heini W. Dirr, Mahmoud E.S. Soliman, and Yasien Sayed</big> <ref> | + | <big>Previn Naicker, Ikechukwu Achilonu, Sylvia Fanucchi, Manuel Fernandes, Mahmoud A.A. Ibrahim, Heini W. Dirr, Mahmoud E.S. Soliman, and Yasien Sayed</big> <ref>doi 10.1080/07391102.2012.736774</ref> |
<hr/> | <hr/> | ||
<b>Molecular Tour</b><br> | <b>Molecular Tour</b><br> | ||
- | The current study reports on the apo crystal structure of the <scene name='Journal:JBSD:36/Cv/3'>South African HIV-1 subtype C protease (C-SA PR)</scene>. Structure of <scene name='Journal:JBSD:36/Cv/4'>unbound HIV-1 PR</scene> with the active site triplet (D25, T26 and G27) shown in ball-and-stick representation, <font color='magenta'><b>hinge region in magenta (residues 35–42 and 57–61)</b></font>, and <span style="color:cyan;background-color:black;font-weight:bold;">flap region (residues 46–54) in cyan</span>. The relevance of this study cannot be underestimated because South Africa is at the epicenter of the HIV/AIDS pandemic. A detailed understanding of the molecular interactions between the drug and its target is required if we are to improve the design of protease inhibitors (PIs). Our study indicated that the loss of a salt bridge between <scene name='Journal:JBSD:36/Cv/5'>residues E35 and R57</scene> at the hinge region affects the flap dynamics of the apo C-SA PR which may reduce the affinity and, therefore, the efficacy of the current protease inhibitors toward the C-SA PR. | + | The current study reports on the apo crystal structure of the <scene name='Journal:JBSD:36/Cv/3'>South African HIV-1 subtype C protease (C-SA PR)</scene>. Structure of <scene name='Journal:JBSD:36/Cv/4'>unbound HIV-1 PR</scene> with the active site triplet (D25, T26 and G27) shown in ball-and-stick representation, <font color='magenta'><b>hinge region in magenta (residues 35–42 and 57–61)</b></font>, and <span style="color:cyan;background-color:black;font-weight:bold;">flap region (residues 46–54) in cyan</span>. The relevance of this study cannot be underestimated because South Africa is at the epicenter of the HIV/AIDS pandemic. A detailed understanding of the molecular interactions between the drug and its target is required if we are to improve the design of protease inhibitors (PIs). Our study indicated that the loss of a salt bridge between <scene name='Journal:JBSD:36/Cv/5'>residues E35 and R57</scene> at the hinge region affects the flap dynamics of the apo C-SA PR which may reduce the affinity and, therefore, the efficacy of the current protease inhibitors toward the C-SA PR (<span style="color:deeppink;background-color:black;font-weight:bold;">subtype C-SA PR is in deeppink</span>, [[3u71]] and <span style="color:yellow;background-color:black;font-weight:bold;">subtype B PR is in yellow</span>, [[2pc0]]). <scene name='Journal:JBSD:36/Cv/6'>Structural alignment</scene> of of the <span style="color:deeppink;background-color:black;font-weight:bold;">C-SA PR (deeppink</span>, PDB ID: [[3u71]]), <span style="color:yellow;background-color:black;font-weight:bold;">consensus subtype B PR (yellow</span>, PDB ID: [[2pc0]]), and <span style="color:wheat;background-color:black;font-weight:bold;">subtype B-MDR PR (color wheat</span>, PDB ID: [[1rp1]]) reveals that the PRs under investigation do not differ significantly. The crystal structure of the C-SA PR will serve as a foundation to improve the rational design of PIs which will have a greater impact on anti-retroviral chemotherapy in sub-Saharan Africa. |
</StructureSection> | </StructureSection> | ||
<references/> | <references/> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ |
Current revision
|
- ↑ Naicker P, Achilonu I, Fanucchi S, Fernandes M, Ibrahim MA, Dirr HW, Soliman ME, Sayed Y. Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance. J Biomol Struct Dyn. 2012 Nov 12. PMID:23140382 doi:10.1080/07391102.2012.736774
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.